DK3995135T3 - Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre - Google Patents

Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre Download PDF

Info

Publication number
DK3995135T3
DK3995135T3 DK20206800.3T DK20206800T DK3995135T3 DK 3995135 T3 DK3995135 T3 DK 3995135T3 DK 20206800 T DK20206800 T DK 20206800T DK 3995135 T3 DK3995135 T3 DK 3995135T3
Authority
DK
Denmark
Prior art keywords
tapentadol
salt
dosage form
tartaric acid
extended release
Prior art date
Application number
DK20206800.3T
Other languages
English (en)
Inventor
Carmen Hartmann
Ulrike Bertram
Ulrich Reinhold
Christian Grosse
Original Assignee
Gruenenthal Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=73343829&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK3995135(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Gruenenthal Gmbh filed Critical Gruenenthal Gmbh
Application granted granted Critical
Publication of DK3995135T3 publication Critical patent/DK3995135T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK20206800.3T 2020-11-10 2020-11-10 Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre DK3995135T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP20206800.3A EP3995135B1 (de) 2020-11-10 2020-11-10 Darreichungsformen mit verlängerter freisetzung eines salzes von tapentadol mit l-(+)-weinsäure

Publications (1)

Publication Number Publication Date
DK3995135T3 true DK3995135T3 (da) 2022-08-22

Family

ID=73343829

Family Applications (1)

Application Number Title Priority Date Filing Date
DK20206800.3T DK3995135T3 (da) 2020-11-10 2020-11-10 Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre

Country Status (10)

Country Link
EP (1) EP3995135B1 (da)
AU (1) AU2021201353B1 (da)
DK (1) DK3995135T3 (da)
ES (1) ES2927147T3 (da)
HR (1) HRP20221136T1 (da)
HU (1) HUE059465T2 (da)
LT (1) LT3995135T (da)
PL (1) PL3995135T3 (da)
PT (1) PT3995135T (da)
RS (1) RS63521B1 (da)

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426245A1 (de) 1994-07-23 1996-02-22 Gruenenthal Gmbh 1-Phenyl-3-dimethylamino-propanverbindungen mit pharmakologischer Wirkung
PE20030527A1 (es) 2001-10-24 2003-07-26 Gruenenthal Chemie Formulacion farmaceutica con liberacion retardada que contiene 3-(3-dimetilamino-1-etil-2-metil-propil) fenol o una sal farmaceuticamente aceptable del mismo y tabletas para administracion oral que la contienen
AR053304A1 (es) 2004-07-01 2007-05-02 Gruenenthal Gmbh Formas farmaceuticas orales protegidas frente al abuso con liberacion controlada de (1r,2r)-3-(3 dimetilamino-1-etil-2metil-propil)fenol y procedimiento para su produccion.
CA2667925A1 (en) 2006-10-27 2008-05-02 Janssen Pharmaceutica N.V. Dry granulated pharmaceutical compositions and methods for producing same
DE102007019417A1 (de) 2007-04-23 2008-11-13 Grünenthal GmbH Tapentadol zur Schmerzbehandlung bei Arthrose
EP2249811A1 (en) 2008-01-25 2010-11-17 Grünenthal GmbH Pharmaceutical dosage form
KR20190026065A (ko) * 2010-07-23 2019-03-12 그뤼넨탈 게엠베하 ３-(３-디메틸아미노-１-에틸-２-메틸-프로필)-페놀의 염 또는 공결정
WO2015014980A1 (en) 2013-08-02 2015-02-05 Ratiopharm Gmbh Composition comprising tapentadol in a dissolved form
CA2943725C (en) * 2014-03-26 2019-06-25 Sun Pharma Advanced Research Company Ltd. Abuse deterrent immediate release coated reservoir solid dosage form
WO2015157150A1 (en) * 2014-04-07 2015-10-15 Banner Life Sciences Llc Opioid abuse-deterrent controlled release formulations
EP2942054A1 (en) 2014-05-09 2015-11-11 G.L. Pharma GmbH Slow-release pharmaceutical formulation
HUE054338T2 (hu) 2015-11-17 2021-08-30 Msn Laboratories Private Ltd Tapentadol sók kristályos formái és eljárás azok elõállítására
WO2018219897A1 (en) * 2017-05-29 2018-12-06 Grünenthal GmbH Multiparticulate oral dosage form providing prolonged release of tapentadol
CN111346077B (zh) * 2018-12-21 2022-06-10 宜昌人福药业有限责任公司 一种他喷他多透皮给药的药物组合物及其制备方法和应用
EP3875079A1 (en) * 2020-03-02 2021-09-08 Grünenthal GmbH Dosage form providing prolonged release of tapentadol phosphoric acid salt

Also Published As

Publication number Publication date
LT3995135T (lt) 2022-08-25
PT3995135T (pt) 2022-09-08
HRP20221136T1 (hr) 2022-11-25
EP3995135A1 (de) 2022-05-11
RS63521B1 (sr) 2022-09-30
HUE059465T2 (hu) 2022-11-28
AU2021201353B1 (en) 2022-04-21
EP3995135B1 (de) 2022-07-13
PL3995135T3 (pl) 2022-10-03
ES2927147T3 (es) 2022-11-02

Similar Documents

Publication Publication Date Title
DK3743411T3 (da) Herbicidt virksomt 3-phenylisoxazolin-5-carboxamider af cyclopentenylcarbonsyrederivater
CY1119731T1 (el) Διαδικασια για την παρασκευη παραγωγων χολικου οξεος
HK1212232A1 (en) Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter
PL3720838T3 (pl) Sole organicznych kwasów sulfonowych i estrów aminokwasów i sposoby ich wytwarzania
DK2467519T4 (da) Hærdbart bindemiddel omfattende aminsalt af uorganisk syre
DK3287123T3 (da) Vandig farmaceutisk formulering af tapentadol til oral administration
DK2717692T3 (da) Tetrahydrocannabinol-11-syrer til anvendelse til behandling af fibrotiske sygdomme
BR112018005075A2 (pt) Síntese de ácido metacrílico a partir de metacrilato de alquila à base de metacroleína
EA201992421A1 (ru) Способ получения озанимода
MA42780A (fr) Sels d'un inhibiteur de la kinase pim
DK3976581T3 (da) Tartaric acid salts of [2-(3-fluoro-5-methane-sulfonylphenoxy)ethyl](propyl)amine
EA201401084A1 (ru) Соли 5-[(1r)-2({2-[4-(2,2-дифтор-2-фенилэтокси)фенил]этил}амино)-1-гидроксиэтил]-8-гидроксихинолин-2(1н)-она
DK3463310T3 (da) Tabletter med højt aktivt indholdsstofindhold af omega-3-fedtsyreaminosyresalte
BR112014018738A8 (pt) Métodos e intermediários para preparo de agentes farmacêuticos
CO2020001807A2 (es) Inhibidores de rorγ
DK3995135T3 (da) Doseringsform med forlænget afgivelse af et salt af tapentadol med l-(+)-vinsyre
DK4114826T3 (da) Krystallinske former af en farmaceutisk forbindelse
DK2245001T3 (da) Fremgangsmåde til fremstilling af 2-fluoracyl-3-amino-acrylsyrederivater
DK3305298T3 (da) Formuleringer af deoxycholsyre og salte deraf
FR2965261B1 (fr) Procede de preparation d'un sel d'acide o-acetylsalicylique d'un acide amine basique et composition obtenue par ce procede
DK4313945T3 (da) Krystallinsk hydrobromidsalt af 5-MeO-DMT
DK2438012T3 (da) Fremgangsmåde til fremstilling af en sammensætning omfattende meso-vinsyre
DK4132909T3 (da) Organiske syreadditionssalte af S-pindolol
DK2691371T3 (da) Benzoesyresalt af otamixaban
IL284865A (en) Method for producing 4-cyano benzoic acid or its salts